U.S. Paper and Forestry Products Stock News

In late July 2026, Modine Manufacturing Company reported first-quarter fiscal 2027 results showing sales of US$874.1 million and net income of US$73.9 million, alongside diluted EPS from continuing operations of US$1.37, and also confirmed it had completed a previously announced buyback of 230,000 shares for US$18.4 million after repurchasing no shares in the most recent quarter. Beyond the quarterly performance, management’s new fiscal 2027 guidance calling for net sales to increase by a...

Globus Medical (GMED) is back in focus after its latest quarterly report, where revenue and earnings per share topped Wall Street estimates. Margin gains and a higher non GAAP EPS outlook are central for investors. See our latest analysis for Globus Medical. The latest earnings beat and higher non-GAAP EPS outlook have coincided with a 7.39% 90-day share price return for Globus Medical, while the year-to-date share price return is still down 5.67%. Over a longer horizon, the 40.41% 1-year...

Luckin Coffee stock has returned 127.4% over the past five years, yet several valuation checks now suggest the current share price may sit below an estimate of intrinsic value. Both a Discounted Cash Flow (DCF) view and earnings-based multiples point in the same direction, which is unusual given the share price has recently been under pressure. Over five years, a 127.4% total return indicates that long term holders have already seen substantial gains. Any current discount to intrinsic value...

Lucid Group earnings jolt investor focus Lucid Group (LCID) has drawn fresh attention after reporting second quarter 2026 results, with sales of US$405.35 million and a net loss of US$1,034.85 million from continuing operations. Over the first six months of 2026, Lucid Group recorded sales of US$687.81 million and a net loss of US$2,063.2 million. This provides investors with updated context on the company’s current scale and ongoing cash burn. See our latest analysis for Lucid Group. Lucid...

In July 2026, Estée Lauder introduced Glimmer, an amber floral prestige fragrance with a gourmand twist, fronted by Hailee Steinfeld in a global TV, print, digital, in-store, and out-of-home campaign, with Eau de Parfum priced at US$130 for 50ml and US$160 for 100ml from August 2026 at key global retailers. This launch signals Estée Lauder’s push to connect with a younger consumer base through emotion-led storytelling and celebrity-driven branding, aiming to convert everyday “glimmers” of...

Raymond James Financial stock has more than doubled over the past five years, and the current price sits against an intrinsic value estimate that suggests meaningful upside while market based multiples look roughly in line with peers. Over the past 5 years, Raymond James Financial has returned 104.8%, which puts extra focus on whether the current price still leaves a margin of safety. The recent hire of a $5.4b advisory team may support expectations for future fee based revenue, while the...

Intapp earnings and guidance draw investor focus Intapp (INTA) is in focus after reporting fourth quarter and full year 2026 results, along with new revenue guidance for fiscal 2027 and an update on its recently completed share repurchase program. The company reported quarterly revenue of US$152.53 million and a net loss of US$5.53 million. For the full year, Intapp posted revenue of US$577.81 million and a net loss of US$41.31 million. Along with these figures, Intapp issued revenue guidance...

Alarm.com Holdings reported past Q2 2026 results showing revenue rising to US$277.73 million, while net income and earnings per share decreased compared with a year earlier, and the company raised its full-year 2026 revenue and non-GAAP EPS guidance. Alongside double-digit SaaS and license revenue growth, Alarm.com highlighted rapid expansion in its commercial and EnergyHub businesses, launched a new Fire Communicator for the large North American fire safety market, and surpassed one million...

Upwork stock is trading near US$9.67 after a difficult few years, and the valuation checks suggest the market may now be pricing it cautiously despite a recent short term rebound. Upwork shareholders have seen the stock decline about 77.3% over the past 5 years, which sets a low bar for any case that today’s price already reflects the company’s potential. The key swing factor for valuation is whether Upwork can turn its marketplace scale into consistently stronger profitability, while the...

In the second quarter of 2026, Veralto Corporation reported higher sales of US$1,474 million and net income of US$241 million year over year, while also completing a US$433.5 million share repurchase program and announcing the acquisition of India-based UV water treatment specialist Alfaa UV. Management emphasized that mergers and acquisitions remain the primary use of capital, highlighting an active deal pipeline and the Alfaa UV bolt-on as a way to strengthen Veralto’s water treatment...

Warrior Met Coal (HCC) is back in focus after its 5 August 2026 earnings release. The company reported updated quarterly results, revised full year 2026 volume guidance, new production targets, and a reaffirmed cash dividend. See our latest analysis for Warrior Met Coal. Warrior Met Coal’s latest earnings and higher 2026 volume guidance have come alongside strong price momentum, with a 7 day share price return of 15.82% and a 1 year total shareholder return of 51.87% pointing to rising...

NI Holdings stock barely moved after earnings, with a 0.5% gain that suggests investors shrugged at the headline. That calm reaction contrasts with a quarterly profit line that almost vanished. Basic earnings per share for Q2 came in around flat at just over US$0.01, following a far stronger start to 2026. The key issue for NI Holdings now appears to be sentiment. The stock carries a trailing P/E of 40.8x while net profit margin sits under 3%. That mix raises a clear question for investors...

Syndax Pharmaceuticals has delivered a 63.5% gain over the past year, yet the broader valuation checks and current market multiples suggest the stock is not an obvious bargain at today’s price of US$20.40. The 63.5% one year return points to strong recent optimism already reflected in Syndax Pharmaceuticals' share price. Progress on its oncology pipeline and upcoming clinical data can support expectations for future revenue, while the execution and clinical risks around those same programs...

In early August 2026, Horace Mann Educators Corporation reported second-quarter revenue of US$443.5 million and net income of US$41.6 million, both higher than a year earlier, alongside record core earnings and an increased 2026 core earnings guidance range of US$4.60–US$4.90 per share. The company also highlighted sharply improved property-and-casualty profitability, with a stronger combined ratio, and announced acquisitions expected to add meaningfully to annual run-rate earnings per share...

Wendy’s stock bounced about 4% to US$7.69 into the first full trading day after earnings, even as the headline story is pressure, not comfort. Same restaurant sales declined 6.3% in the quarter and global systemwide sales fell 6.5%. That mix of a cheaper stock on an earnings pop and falling traffic is what matters for you as an investor. In the near term, the focus is on weaker guest counts and a thinner 5.7% trailing net margin. Over the longer term, the key question is whether the new...

The fight over Fifa’s abandoned $4.2b World Cup stake has drawn attention to something bigger. Tech investors are hunting for assets that feel resilient as AI reshapes movies, games and streaming, and global sports sit right in that crosshairs. For anyone focused on where long term attention and money may concentrate, this matters. This article breaks down three stocks tied to that story and explains how the same news affects each of them. Manchester United (MANU) Manchester United runs one...

Ziff Davis (ZD) stock is in focus after the company reported second quarter 2026 results, with sales of US$286.74 million, a sharp swing in net income, and a loss from continuing operations. See our latest analysis for Ziff Davis. The earnings update and the sale of the connectivity business to Accenture for about US$1.2b have come alongside strong recent momentum in Ziff Davis, with a 90 day share price return of 28.58% and a 1 year total shareholder return of 46.86%, although the 5 year...

Why Option Care Health stock is in focus after its latest update Option Care Health (OPCH) is drawing fresh attention after reporting second quarter 2026 results, with revenue, EBITDA, and EPS ahead of expectations, while keeping guidance unchanged and continuing investments in digital tools and infusion clinic expansion. See our latest analysis for Option Care Health. Against this backdrop, Option Care Health's recent earnings and buyback activity appear to be supporting improving sentiment...

In early August 2026, MetLife, Inc. reported second-quarter revenue of US$19,154 million and net income of US$736 million, alongside higher diluted earnings per share from continuing operations versus a year earlier, and stronger results for the first half of 2026. On the same day, MetLife’s board authorized a new US$3.00 billion share repurchase program after completing US$2.63 billion of buybacks since April 2025, underscoring the insurer’s current emphasis on returning capital to...

Gray Media stock exploded 25% higher to US$5.37 after the Q2 report, a sharp move for a regional television and media operator that has been wrestling with losses. The headline number was Q2 revenue of US$839 million, helped by US$83 million of political advertising that came in ahead of expectations. Basic earnings per share remained in loss territory, although the loss narrowed compared with recent quarters. For short term traders, the pop is the story. For longer term holders, the bigger...

Zai Lab stock has rebounded sharply over the short term, yet its longer term share price record and current valuation checks point to a more cautious picture for investors trying to judge what the recent move really means. Over the past 5 years, Zai Lab has fallen about 84.5%, which leaves long term holders with a material drawdown even after the recent bounce. Regulatory progress such as Orphan Drug Designation for its DLL3-targeting therapy Zocilurtatug Pelitecan can support expectations...

Lineage earnings snapshot after second quarter results Lineage (LINE) released second quarter 2026 earnings on 5 August, with sales of US$1.361b and a net loss of US$29 million. That compares with sales of US$1.350b and a US$6 million loss a year earlier. For the first half of 2026, Lineage reported sales of US$2.658b and a net loss of US$75 million. Basic and diluted loss per share from continuing operations was US$0.31, compared with US$0.02 for the same period in 2025. See our latest...

Celldex Therapeutics stock has more than doubled over the past year, yet the latest valuation checks and market multiples suggest the shares lean expensive rather than clearly cheap. The 101.9% return over the past year highlights how strongly sentiment has shifted toward Celldex Therapeutics, which raises the bar for what the current price can justify. Progress in Celldex Therapeutics' barzolvolimab and CDX-622 programs can support expectations for future growth. However, trial setbacks or...

FuboTV stock has seen a very steep long term decline, yet its current valuation checks still suggest the shares may be pricing in more pessimism than the fundamentals imply. FuboTV shareholders have seen the stock fall about 97.3% over the past 5 years, which means current buyers are looking at a very different risk and reward profile to those who bought earlier in its story. Future revenue growth and progress toward more consistent cash generation can support the current valuation, while...